De-Risk Supply Disruptions Through Flexible Manufacturing Capacity

Biotech, Drug Discovery & Development, Life Science, Medical Device, Pharma, Pharma Manufacturing & Supply Chain,
  • Tuesday, April 21, 2026 | 10am EDT (NA) / 3pm BST (UK) / 4pm CEST (EU-Central)
  • 60 min

Manufacturing strategy has become a defining capital allocation decision with long-term operational and financial implications. Tariff instability, demand volatility and margin pressure are prompting leaders to reassess how manufacturing capacity is structured and financed. This webinar explores practical models that increase flexibility, improve capital efficiency and reduce fixed-cost exposure.

Rather than focusing solely on risk avoidance, the webinar will outline actionable approaches to modernizing manufacturing capacity. The featured speakers will examine how asset-light manufacturing models reduce fixed-cost burden and help organizations avoid the CapEx trap. They will also address how distributed, dual-site production strengthens supply continuity and mitigates disruption risk in increasingly complex global networks.

In addition, attendees will learn how variable-cost capacity structures enable faster scaling, seasonal surge response and more disciplined alignment with portfolio demand. Lastly, the speakers will also highlight how embedded scientific and engineering support can accelerate innovation without requiring significant internal infrastructure investment.

Register for this webinar to learn how manufacturing capacity strategies can improve flexibility, protect margins and strengthen long-term operational resilience.

Speaker

M. Scott Carpenter, Formulated Solutions

Scott Carpenter, VP Partner Innovation, Marketing, and Business Development, Formulated Solutions

Scott Carpenter is Vice President of Partner Innovation, Marketing and Business Development at Formulated Solutions, a U.S.-based CDMO supporting leading consumer health and pharmaceutical brands. With over 25 years of experience across Bayer, Merck, SC Johnson, Nabisco, and other global organizations, Scott has led product innovations that have generated over $1 billion in retail revenue and holds more than 40 patents.

He specializes in asset-light manufacturing strategy, portfolio expansion and helping brand owners accelerate commercialization while reducing capital risk. Scott frequently speaks on capital efficiency, domestic manufacturing strategy and the evolving role of CDMOs in today’s volatile market environment.

Message Presenter

Who Should Attend?

This webinar is designed for:

  • Chief Commercial Officers
  • Chief Financial Officers
  • SVP/VP Operations
  • Supply Chain Leaders
  • Manufacturing Strategy Directors
  • Portfolio & Innovation Leaders
  • Corporate Development & Market Entry Teams

Particularly relevant for companies in consumer health, OTC, medical devices and specialty pharmaceuticals facing scaling, domestic production or tariff-related decisions.

What You Will Learn

Attendees will learn:

  • How asset-light manufacturing reduces fixed-cost exposure and avoids the CapEx trap
  • How distributed, dual-site production improves supply continuity and mitigates risk
  • How variable-cost capacity enables faster scaling and seasonal surge response
  • How embedded scientific and engineering support accelerates innovation without internal infrastructure

Xtalks Partner

Formulated Solutions

Formulated Solutions is a U.S.-based Contract Development and Manufacturing Organization specializing in advanced non-sterile, small molecule, topical, nasal, and liquid oral dose OTC drugs, medical devices, and consumer healthcare products. With industry-leading expertise across aerosols, semisolids, liquids, and innovative dispensing systems, the company helps partners transform complex ideas into high-quality, FDA-compliant commercial products.

Operating from two U.S. manufacturing sites with redundant capabilities, Formulated Solutions offers exceptional scalability, from tens of thousands to tens of millions of units, ensuring supply reliability even during seasonal spikes or unexpected market shifts. The organization combines strong regulatory support, deep scientific and engineering resources, and a proven track record of developing and improving formulas.

Known for smart, asset-light partnerships, Formulated Solutions enables customers to avoid large capital investments while accelerating development, strengthening quality, and improving speed to market. The company is trusted by top global healthcare brands for its innovation, technical strength, and unwavering commitment to consumer safety and product performance.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account